Top compounds associated with response to NRTN

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.12	0.0004
mRNA	RG-108	CTRPv2	pan-cancer	AAC	0.13	0.0004
mRNA	RDEA119	GDSC1000	pan-cancer	AAC	-0.11	0.0005
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.12	0.0005
mRNA	Cetuximab	GDSC1000	pan-cancer	AAC	-0.12	0.0006
mRNA	CI-1040	GDSC1000	pan-cancer	AAC	-0.12	0.0006
mRNA	Docetaxel	GDSC1000	pan-cancer	AAC	-0.11	0.0006
mRNA	barasertib	CTRPv2	pan-cancer	AAC	0.11	0.0007
mRNA	NVP-BEZ235	GDSC1000	pan-cancer	AAC	-0.12	0.0007
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.12	0.0007

Download CSV